Posts tagged with: "Avandia" Results 441 - 460 of 886
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Feb 2010, 1:24 pm
GlaxoSmithKline’s own study of Avandia, conducted with i3 Drug Safety, an independent drug safety firm, found that Avandia users have a 35 percent to 41 percent increased risk of heart attack over users of Actos, Avandia’s main competitor. [read post]
8 Jul 2010, 10:39 am
If you or a loved one uses Avandia, you are encouraged to speak to your doctor immediately. [read post]
16 Feb 2012, 5:14 am
A relative of the now-discredited drug Avandia, Actos has been investigated for some of the same cardiovascular safety flaws Avandia has. [read post]
10 Oct 2010, 5:58 pm by Larry Jones
 Here is a nice post from Forbes Magazine's online edition that discusses the changing environment at the Food and Drug Administration since the Vioxx and Avandia messes. [read post]
7 Mar 2012, 12:18 pm by eithurburn@getnicklaw.com
  The company allegedly wanted to make its drug, Actos, appear safer than the competitor drug manufactured by GlaxoSmithKline, Avandia. [read post]
26 Nov 2008, 3:17 am
Elderly diabetics taking the drug rosiglitazone, which is sold under the brand name Avandia, face a greater risk of developing congestive heart failure a Harvard Medical School report has found, according to the New York Times, "Diabetes Drug Linked To Higher Rate Of Death. [read post]
12 Oct 2010, 5:30 pm by Larry Jones
  At the gathering, lawyers from around the country who are handling cases like Yaz, DePuy, Mirapex, Avandia, Wellbutrin and other mass tort cases exchange ideas and plot case strategy. [read post]
2 Apr 2009, 12:26 pm
In addition, there have been several studies which show that Avandia may significantly increase the risk of having a heart attack, or myocardial infarction (MI). [read post]
24 Aug 2010, 6:11 am by Mark Zamora
Excerpt from the Tide Trial letter:  Last week we infonned you of the United States Food and Drug Administration's (FDA)decision to place a partial clinical hold on the TIDE trial (i.e. to continue following randomizedparticipants but to not randomize new participants). [read post]
11 Feb 2008, 9:50 pm
Silverman:The results of the ACCORD trial, which was designed to determine whether treating diabetes would reduce heart disease, found that no particular drug was responsible for serious cardiovascular problems. [read post]
4 Nov 2011, 5:13 am by Brian Wolfman
This Washington Post article describes a reported settlement between GlaxoSmithKline and the U.S. government over charges that the drug company fraudulently advertised a number of its drugs, including the diabetes drug Avandia, which has been linked to increased risk of heart attack and stroke. [read post]
4 Nov 2010, 10:41 am
As if GlaxoSmithKline's (GSK) problems with the popular diabetes drug Avandia weren't enough, the global drug manufacturer recently had to pay $1 billion to settle approximately 800 Paxil lawsuits. [read post]
3 Nov 2011, 2:00 pm
The case dates from 2004, and included investigations of possible price irregularities and the development and marketing of the diabetes drug Avandia. [read post]
13 Aug 2010, 3:46 am by Bob Kraft
Time Magazine reports that the FDA panel's recent decision to recommend keeping Avandia (rosiglitazone) on the market is "a move worth billions of dollars to GSK but that also may have put millions of patients at risk. [read post]
4 Nov 2011, 10:04 pm by eithurburn@getnicklaw.com
  Among the allegations resolved by the settlement are its development and marketing of Avandia, a diabetes drug that has been linked to heart risks, improper marketing of Paxil and Wellbutrin between 1997 and 2004, and abusive Medicaid billing practices. [read post]
18 Jul 2007, 4:30 am
Here there is news that can best be described as a threat directly to attorneys:Glaxo has sent letters to lawyers advertising for cases over the Avandia diabetes drug, demanding that they pull what the company contends are false or misleading ads. [read post]
23 Nov 2010, 8:00 am by Sean Wajert
In the MDL involving the the diabetes medication Avandia, In re Avandia Marketing, Sales Practices, and Products Liab. [read post]
14 Jul 2010, 5:40 am by Stephen Gillers
We don't know whether lawyers at SmithKline Beecham were aware of the suppressed information, reported in the Times and Journal yesterday, that showed that its diabetes medicine, Avandia, might actually be "riskier to the heart" than a competitor's product (and in any event not better). [read post]